Back Home Search

RAS, MEK, or NF1 driver mutated gynecologic cancer

  • Gynecologic cancer1
  • KRAS G12C in NSCLC and CRC1
  • Protocols
  • UW23025

    OPEN TO ACCRUAL

    Ph 1 Study of LUNA18 Monotherapy & Combination in Pts w/ Locally Advanced or Metastatic Solid Tumors

  • UW23105

    OPEN TO ACCRUAL

    Ph 1/2 Study of DCC-3116 w/ RAS/MAPK Pathway Inhibitors in Pts w/ Solid Tumors w/ RAS/MAPK Mutations